- Report
- February 2026
- 169 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 304 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 194 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 118 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 297 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 136 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 189 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 181 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 268 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 373 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 169 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 265 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 186 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 381 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 283 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 134 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 286 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 193 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 390 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 287 Pages
Global
From €5101EUR$5,850USD£4,435GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more